Cargando…

Tyrosine kinase inhibitor prophylaxis after transplant for Philadelphia chromosome‐positive acute lymphoblastic leukemia

Tyrosine kinase inhibitor (TKI) administration after allogeneic hematopoietic stem cell transplantation (HSCT) may carry a survival benefit in Philadelphia chromosome‐positive acute lymphoblastic leukemia (Ph+ ALL). Therefore, we investigated whether TKI prophylaxis for negative‐minimal residual dis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Akahoshi, Yu, Nishiwaki, Satoshi, Mizuta, Shuichi, Ohashi, Kazuteru, Uchida, Naoyuki, Tanaka, Masatsugu, Fukuda, Takahiro, Ozawa, Yukiyasu, Takahashi, Satoshi, Onizuka, Makoto, Shiratori, Souichi, Nakamae, Hirohisa, Kanda, Yoshinobu, Ichinohe, Tatsuo, Atsuta, Yoshiko, Kako, Shinichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778639/ https://www.ncbi.nlm.nih.gov/pubmed/31402561 http://dx.doi.org/10.1111/cas.14167

Ejemplares similares

HLA discrepancy between graft and host rather than that graft and first donor impact the second transplant outcome
por: Maeda, Yoshinobu, et al.
Publicado: (2019)

CMV reactivation after allogeneic HCT is associated with a reduced risk of relapse in acute lymphoblastic leukemia
por: Akahoshi, Yu, et al.
Publicado: (2023)

Association Between Candidemia and Noninfectious Interstitial Pneumonia After Allogeneic Hematopoietic Cell Transplantation: JSTCT Transplant Complications Working Group
por: Kimura, Shun-ichi, et al.
Publicado: (2023)

Adult patients with Ph+ ALL benefit from conditioning regimen of medium‐dose VP16 plus CY/TBI
por: Morita‐Fujita, Mari, et al.
Publicado: (2022)

Improvements in allogeneic hematopoietic cell transplantation outcomes for adults with ALL over the past 3 decades
por: Nishiwaki, Satoshi, et al.
Publicado: (2022)

Author Correction: A convolutional neural network-based model that predicts acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
por: Jo, Tomoyasu, et al.
Publicado: (2023)

A convolutional neural network-based model that predicts acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
por: Jo, Tomoyasu, et al.
Publicado: (2023)

Novel risk assessment for the intensity of conditioning regimen in older patients
por: Akahoshi, Yu, et al.
Publicado: (2022)

Impact of HLA Epitope Matching on Outcomes After Unrelated Bone Marrow Transplantation
por: Iwasaki, Makoto, et al.
Publicado: (2022)

P1306: IMPACT OF HLA DISPARITY ON THE RISK OF OVERALL MORTALITY IN PATIENTS WITH EXTENSIVE CHRONIC GVHD
por: Fuji, Shigeo, et al.
Publicado: (2023)

High-risk Combinations of Additional Chromosomal Abnormalities in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia: JALSG Ph+ALL TKI-SCT Study
por: Nishiwaki, Satoshi, et al.
Publicado: (2023)

Effect of the COVID-19 pandemic on allogeneic stem cell transplantation in Japan
por: Shimomura, Yoshimitsu, et al.
Publicado: (2022)

Improved trends in survival and engraftment after single cord blood transplantation for adult acute myeloid leukemia
por: Konuma, Takaaki, et al.
Publicado: (2022)

Clinical significance of high-dose cytarabine added to cyclophosphamide/total-body irradiation in bone marrow or peripheral blood stem cell transplantation for myeloid malignancy
por: Arai, Yasuyuki, et al.
Publicado: (2015)

Impact of anti-thymocyte globulin on survival outcomes in female-to-male allogeneic hematopoietic stem cell transplantation
por: Tamaki, Masaharu, et al.
Publicado: (2023)

Machine learning-aided risk stratification in Philadelphia chromosome-positive acute lymphoblastic leukemia
por: Nishiwaki, Satoshi, et al.
Publicado: (2021)

Poor outcome of allogeneic transplantation for therapy-related acute myeloid leukemia induced by prior chemoradiotherapy
por: Araie, Hiroaki, et al.
Publicado: (2023)

Should a matched sibling donor still be considered the primary option for allogeneic hematopoietic cell transplantation in patients over 50 years of age with myelodysplastic syndrome?
por: Konuma, Takaaki, et al.
Publicado: (2023)

Syngeneic hematopoietic stem cell transplantation for acute myeloid leukemia: a propensity score-matched analysis
por: Kurosawa, Shuhei, et al.
Publicado: (2021)

P1323: THE PROGNOSIS AND COMPLICATIONS OF PATIENTS WITH PRE-TRANSPLANT LIVER DYSFUNCTION
por: Misaki, Yukiko, et al.
Publicado: (2023)

P1261: NEGATIVE IMPACT OF HLA-B LEADER MISMATCH ON OUTCOMES OF HCT WITH PTCY FOR LYMPHOID MALIGNANCIES: A RETROSPECTIVE ANALYSIS FROM THE JAPANESE SOCIETY FOR TRANSPLANTATION AND CELLULAR THERAPY
por: Kanaya, Minoru, et al.
Publicado: (2023)

Dasatinib-based 2-step induction for adults with Philadelphia chromosome–positive acute lymphoblastic leukemia
por: Sugiura, Isamu, et al.
Publicado: (2022)

Cytomegalovirus gastroenteritis in patients with acute graft-versus-host disease
por: Akahoshi, Yu, et al.
Publicado: (2022)

Allogeneic Hematopoietic Stem Cell Transplantation for Post-essential Thrombocythemia and Post-polycythemia Vera Myelofibrosis
por: Murata, Makoto, et al.
Publicado: (2020)

Late mortality and causes of death among long-term survivors after autologous hematopoietic stem cell transplantation
por: Iida, Minako, et al.
Publicado: (2020)

Outcomes after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia patients with der(1;7)(q10;p10)
por: Mizumaki, Hiroki, et al.
Publicado: (2022)

Multi-Lineage BCR-ABL Expression in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Is Associated With Improved Prognosis but No Specific Molecular Features
por: Nishiwaki, Satoshi, et al.
Publicado: (2020)

P1265: UNRELATED FEMALE-TO-MALE BONE MARROW TRANSPLANTATION SHOULD BE PREFERRED OVER CORD BLOOD TRANSPLANTATION IN MALE RECIPIENTS.
por: Tamaki, Masaharu, et al.
Publicado: (2023)

Deletion of Y chromosome before allogeneic hematopoietic stem cell transplantation in male recipients with female donors
por: Tamaki, Masaharu, et al.
Publicado: (2022)

Improved survival of multiple myeloma patients treated with autologous transplantation in the modern era of new medicine
por: Shimazu, Yutaka, et al.
Publicado: (2021)

Changing trends in the risk factors for second primary malignancies after autologous stem cell transplantation for multiple myeloma before and after the introduction of proteasome inhibitors and immunomodulatory drugs
por: Takamatsu, Hiroyuki, et al.
Publicado: (2023)

Personalized prediction of overall survival in patients with AML in non‐complete remission undergoing allo‐HCT
por: Hirabayashi, Shigeki, et al.
Publicado: (2021)

Timely Diagnosis and Successful Treatment of Intravascular Large B-Cell Lymphoma in an Elderly Patient with Poor Performance Status
por: Kaito, Satoshi, et al.
Publicado: (2019)

A Safety and Efficacy Study of Medium-Dose Etoposide, Cyclophosphamide and Total Body Irradiation Conditioning Before Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukemia
por: Shigematsu, Akio, et al.
Publicado: (2015)

Randomised controlled trial of conditioning regimen for cord blood transplantation for adult myeloid malignancies comparing high-dose cytarabine/cyclophosphamide/total body irradiation with versus without G-CSF priming: G-CONCORD study protocol
por: Terakura, Seitaro, et al.
Publicado: (2020)

Graft-versus-MDS effect after unrelated cord blood transplantation: a retrospective analysis of 752 patients registered at the Japanese Data Center for Hematopoietic Cell Transplantation
por: Ishiyama, Ken, et al.
Publicado: (2019)

Dasatinib and Prednisolone Induction Therapy for a Case of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia with Dilated Cardiomyopathy Accompanied by Life-Threatening Ventricular Tachycardia
por: Nishimoto, Mitsutaka, et al.
Publicado: (2017)

Peritransplant glucocorticoids redistribute donor T cells to the bone marrow and prevent relapse after haploidentical SCT
por: Inoue, Takayuki, et al.
Publicado: (2021)

Possible Association between Recurrent Chronic Subdural Hematoma and Dural Arteriovenous Fistula: A Case Report with Three-dimensional Fusion Images
por: YAJIMA, Hirohisa, et al.
Publicado: (2023)

RUNX1 transactivates BCR‐ABL1 expression in Philadelphia chromosome positive acute lymphoblastic leukemia
por: Masuda, Tatsuya, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dneim41lld6rd3ul59ospkqark